BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33098164)

  • 21. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.
    Sweeney CL; Zou J; Choi U; Merling RK; Liu A; Bodansky A; Burkett S; Kim JW; De Ravin SS; Malech HL
    Mol Ther; 2017 Feb; 25(2):321-330. PubMed ID: 28153086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive HIV serology, Candida lusitaniae pneumonia, and a novel mutation in the CYBB gene.
    Banday AZ; Nataraj L; Jindal AK; Kaur H; Gummadi A; Sharma M; Pandiarajan V; Rawat A
    Immunobiology; 2021 Jul; 226(4):152110. PubMed ID: 34242877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
    von Goessel H; Hossle JP; Seger R; Gungor T
    Exp Hematol; 2006 Apr; 34(4):528-35. PubMed ID: 16569599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47-phox defect.
    Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Bazargan N; Movahedi M; Mahlouji Rad M; Mahdaviani SA; Mamishi S; Khotaei GT; Mansouri D; Zandieh F; Pourpak Z
    Scand J Immunol; 2019 Jul; 90(1):e12767. PubMed ID: 30963593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
    Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
    J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of IL2RG and CYBB mutations in two Chinese primary immunodeficiency patients by whole-exome sequencing.
    Xu S; Li Q; Wu J; Chen G; Zhu B; Gu W
    Immunol Invest; 2018 Apr; 47(3):221-228. PubMed ID: 29388853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsense mutations of the CYBB gene in two Thai families with X-linked chronic granulomatous disease.
    Vilaiphan P; Chatchatee P; Ngamphaiboon J; Tongkobpetch S; Suphapeetiporn K; Shotelersuk V
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):243-7. PubMed ID: 18402298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic analysis of 13 families with X-linked chronic granulomatous disease reveals a low proportion of sporadic patients and a high proportion of sporadic carriers.
    Ariga T; Furuta H; Cho K; Sakiyama Y
    Pediatr Res; 1998 Jul; 44(1):85-92. PubMed ID: 9667376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
    Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
    BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
    Martel C; Mollin M; Beaumel S; Brion JP; Coutton C; Satre V; Vieville G; Callanan M; Lefebvre C; Salmon A; Pagnier A; Plantaz D; Bost-Bru C; Eitenschenck L; Durieu I; Floret D; Galambrun C; Chambost H; Michel G; Stephan JL; Hermine O; Blanche S; Blot N; Rubié H; Pouessel G; Drillon-Haus S; Conrad B; Posfay-Barbe KM; Havlicekova Z; Voskresenky-Baricic T; Jadranka K; Arriazu MC; Garcia LA; Sfaihi L; Bordigoni P; Stasia MJ
    J Clin Immunol; 2012 Oct; 32(5):942-58. PubMed ID: 22562447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.
    Rae J; Newburger PE; Dinauer MC; Noack D; Hopkins PJ; Kuruto R; Curnutte JT
    Am J Hum Genet; 1998 Jun; 62(6):1320-31. PubMed ID: 9585602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
    Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
    Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
    Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
    Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
    Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.
    Patiño PJ; Perez JE; Lopez JA; Condino-Neto A; Grumach AS; Botero JH; Curnutte JT; García de Olarte D
    Hum Mutat; 1999; 13(1):29-37. PubMed ID: 9888386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.